B, S., R, S., Y, L., LR, B., Y, H., I, M., . . . P, H. Economic Impact of Elranatamab for Treatment of Patients with Relapsed or Refractory Multiple Myeloma. Dove Medical Press.
Chicago Style (17th ed.) CitationB, Shah, et al. Economic Impact of Elranatamab for Treatment of Patients with Relapsed or Refractory Multiple Myeloma. Dove Medical Press.
MLA (9th ed.) CitationB, Shah, et al. Economic Impact of Elranatamab for Treatment of Patients with Relapsed or Refractory Multiple Myeloma. Dove Medical Press.
Warning: These citations may not always be 100% accurate.